Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption

  • Alfonso Iorio, Sangeeta Krishnan, Karl-Johan Myrén, Stefan Lethagen, Nora McCormick, Sander Yermakov, Paul Karner
  • Journal of Medical Economics, December 2016, Taylor & Francis
  • DOI: 10.1080/13696998.2016.1265973

The authors haven't yet claimed this publication.

Read Publication